Cargando…

Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity

Monogenic obesity is a severe, genetically determined disorder that affects up to 1/1000 newborns. Recent reports on potential new therapeutics and innovative clinical approaches have highlighted the need for early identification of individuals with rare genetic variants that can alter the functioni...

Descripción completa

Detalles Bibliográficos
Autores principales: Šket, Robert, Kotnik, Primož, Bizjan, Barbara Jenko, Kocen, Valentina, Mlinarič, Matej, Tesovnik, Tine, Debeljak, Maruša, Battelino, Tadej, Kovač, Jernej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105721/
https://www.ncbi.nlm.nih.gov/pubmed/35574020
http://dx.doi.org/10.3389/fendo.2022.832911
_version_ 1784708110123794432
author Šket, Robert
Kotnik, Primož
Bizjan, Barbara Jenko
Kocen, Valentina
Mlinarič, Matej
Tesovnik, Tine
Debeljak, Maruša
Battelino, Tadej
Kovač, Jernej
author_facet Šket, Robert
Kotnik, Primož
Bizjan, Barbara Jenko
Kocen, Valentina
Mlinarič, Matej
Tesovnik, Tine
Debeljak, Maruša
Battelino, Tadej
Kovač, Jernej
author_sort Šket, Robert
collection PubMed
description Monogenic obesity is a severe, genetically determined disorder that affects up to 1/1000 newborns. Recent reports on potential new therapeutics and innovative clinical approaches have highlighted the need for early identification of individuals with rare genetic variants that can alter the functioning of the leptin-melanocortin signalling pathway, in order to speed up clinical intervention and reduce the risk of chronic complications. Therefore, next-generation DNA sequencing of central genes in the leptin-melanocortin pathway was performed in 1508 children and adolescents with and without obesity, aged 2-19 years. The recruited cohort comprised approximately 5% of the national paediatric population with obesity. The model-estimated effect size of rare variants in the leptin-melanocortin signalling pathway on longitudinal weight gain between carriers and non-carriers was derived. In total, 21 (1.4%) participants had known disease-causing heterozygous variants (DCVs) in the genes under investigation, and 62 (4.1%) participants were carriers of rare variants of unknown clinical significance (VUS). The estimated frequency of potential genetic variants associated with obesity (including rare VUS) ranged between 1/150 (VUS and DCV) and 1/850 (DCV) and differed significantly between participants with and without obesity. On average, the variants identified would result in approximately 7.6 kg (7.0-12.9 kg at the 95th percentile of body weight) (girls) and 8.4 kg (8.2-14.4 kg) (boys) of additional weight gain in carriers at age 18 years compared with subjects without obesity. In conclusion, children with a genetic predisposition to obesity can be promptly identified and may account for more than 6% of obesity cases. Early identification of genetic variants in the LEPR, PCSK1, POMC, MC3R and MC4R genes could reduce the societal burden and improve the clinical management of early severe childhood obesity and its implementation should be further investigated.
format Online
Article
Text
id pubmed-9105721
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91057212022-05-14 Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity Šket, Robert Kotnik, Primož Bizjan, Barbara Jenko Kocen, Valentina Mlinarič, Matej Tesovnik, Tine Debeljak, Maruša Battelino, Tadej Kovač, Jernej Front Endocrinol (Lausanne) Endocrinology Monogenic obesity is a severe, genetically determined disorder that affects up to 1/1000 newborns. Recent reports on potential new therapeutics and innovative clinical approaches have highlighted the need for early identification of individuals with rare genetic variants that can alter the functioning of the leptin-melanocortin signalling pathway, in order to speed up clinical intervention and reduce the risk of chronic complications. Therefore, next-generation DNA sequencing of central genes in the leptin-melanocortin pathway was performed in 1508 children and adolescents with and without obesity, aged 2-19 years. The recruited cohort comprised approximately 5% of the national paediatric population with obesity. The model-estimated effect size of rare variants in the leptin-melanocortin signalling pathway on longitudinal weight gain between carriers and non-carriers was derived. In total, 21 (1.4%) participants had known disease-causing heterozygous variants (DCVs) in the genes under investigation, and 62 (4.1%) participants were carriers of rare variants of unknown clinical significance (VUS). The estimated frequency of potential genetic variants associated with obesity (including rare VUS) ranged between 1/150 (VUS and DCV) and 1/850 (DCV) and differed significantly between participants with and without obesity. On average, the variants identified would result in approximately 7.6 kg (7.0-12.9 kg at the 95th percentile of body weight) (girls) and 8.4 kg (8.2-14.4 kg) (boys) of additional weight gain in carriers at age 18 years compared with subjects without obesity. In conclusion, children with a genetic predisposition to obesity can be promptly identified and may account for more than 6% of obesity cases. Early identification of genetic variants in the LEPR, PCSK1, POMC, MC3R and MC4R genes could reduce the societal burden and improve the clinical management of early severe childhood obesity and its implementation should be further investigated. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9105721/ /pubmed/35574020 http://dx.doi.org/10.3389/fendo.2022.832911 Text en Copyright © 2022 Šket, Kotnik, Bizjan, Kocen, Mlinarič, Tesovnik, Debeljak, Battelino and Kovač https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Šket, Robert
Kotnik, Primož
Bizjan, Barbara Jenko
Kocen, Valentina
Mlinarič, Matej
Tesovnik, Tine
Debeljak, Maruša
Battelino, Tadej
Kovač, Jernej
Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity
title Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity
title_full Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity
title_fullStr Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity
title_full_unstemmed Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity
title_short Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity
title_sort heterozygous genetic variants in autosomal recessive genes of the leptin-melanocortin signalling pathway are associated with the development of childhood obesity
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105721/
https://www.ncbi.nlm.nih.gov/pubmed/35574020
http://dx.doi.org/10.3389/fendo.2022.832911
work_keys_str_mv AT sketrobert heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT kotnikprimoz heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT bizjanbarbarajenko heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT kocenvalentina heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT mlinaricmatej heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT tesovniktine heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT debeljakmarusa heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT battelinotadej heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity
AT kovacjernej heterozygousgeneticvariantsinautosomalrecessivegenesoftheleptinmelanocortinsignallingpathwayareassociatedwiththedevelopmentofchildhoodobesity